Gritstone bio, Inc. (GRTSQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Feb 21, 2025, 4:00 PM EST
Gritstone bio Employees
Gritstone bio had 231 employees as of December 31, 2023. The number of employees decreased by 2 or -0.86% compared to the previous year.
Employees
231
Change (1Y)
-2
Growth (1Y)
-0.86%
Revenue / Employee
$63,247
Profits / Employee
-$575,900
Market Cap
148.00
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
CytoDyn | 9 |
Northwest Biotherapeutics | 25 |
SANUWAVE Health | 31 |
Silence Therapeutics | 109 |
Gritstone bio News
- 3 months ago - Gritstone bio Announces Strengthening of Maturing Phase 2 PFS Data for GRANITE Study and Provides Business Update - GlobeNewsWire
- 4 months ago - Bankrupt Gritstone bio in funding talks - Seeking Alpha
- 4 months ago - Covid-Shot Maker Goes Bankrupt After Trailing Pfizer, Moderna - BNN Bloomberg
- 4 months ago - Gritstone bio files for Chapter 11 bankruptcy protection, shares tumble - Seeking Alpha
- 5 months ago - Gritstone downgraded by Jones, B. Riley over cancer vaccine data - Seeking Alpha
- 5 months ago - Penny Stock Gritstone Bio Hires Advisor To Evaluate Options, Analyst Downgrades Stock As Data 'Insufficient To Excite Many Investors' - Benzinga
- 5 months ago - Gritstone stock craters 50% in wake of Phase 2 data, corporate update - Seeking Alpha
- 5 months ago - Gritstone falls amid Phase 2 Granite data, corporate update - Seeking Alpha